AVaTAR MedTech
Buenos Aires, Argentina· Est.
Innovative autologous valve reconstruction platform for pediatric and adult heart disease.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Innovative autologous valve reconstruction platform for pediatric and adult heart disease.
CardiologyCongenital Heart Disease
Technology Platform
Autologous tissue valve reconstruction using additive‑manufactured surgical instruments to create growth‑accommodating semilunar valves without permanent implants.
Opportunities
Large unmet need for growth‑accommodating, anticoagulation‑free valve solutions in pediatric cardiac surgery and a expanding market for adult valve repair.
Risk Factors
Regulatory approval timelines, scale‑up of manufacturing, and competition from established prosthetic valve manufacturers.
Competitive Landscape
Competes with mechanical, bioprosthetic, and transcatheter valves; differentiation lies in autologous tissue use, growth accommodation, and single‑use surgical instruments.